Herpes simplex virus-mediated regulation of host gene expression

单纯疱疹病毒介导的宿主基因表达调控

基本信息

项目摘要

Project summary: Herpes simplex virus 1 (HSV-1) is a highly contagious pathogen that causes a number of diseases ranging from painful skin lesions to keratitis and encephalitis. The gene expression program of HSV-1 has been extensively studied for the past several decades. Despite the intensive effort, however, it remains unclear how HSV-1 suppresses host gene expression to allow efficient viral replication. Genetic studies have demonstrated that ICP27, encoded by an essential immediate early gene, plays an essential role in the inhibition of host mRNA biogenesis. Based on in vitro assays, earlier studies have suggested that ICP27 blocks transcription and splicing of host genes. Through high throughput analyses of host gene expression following HSV-1 infection or ICP27 overexpression, however, recent studies detected no global inhibition of either transcription or splicing, but only splicing changes in a small number of genes. Interestingly, these studies found that there was widespread transcription termination defect in HSV-1-infected cells and that this inhibition was specific to host genes. Although these recent studies provided important insight into HSV-1-induced host shutoff, the molecular mechanisms underlying HSV-1-mediated block of transcription termination remain completely unknown and it is unclear whether such a block is required for efficient viral replication. We aim to address these important questions in this proposal. In our preliminary studies, we found that ICP27 specifically interacts with the essential mRNA 3' processing factor CPSF and that ICP27 blocks mRNA 3' processing. Since mRNA 3' processing is required for transcription termination, we will test the hypothesis that ICP27 inhibits host transcription termination by blocking mRNA 3' processing via CPSF, and that ICP27-mediated disruption of host mRNA processing is important for HSV replication.
项目概要: 单纯疱疹病毒1(HSV-1)是一种高度传染性的病原体, 从疼痛的皮肤损伤到角膜炎和脑炎。基因 HSV-1的表达程序在过去的几年中已经被广泛研究, 几十年然而,尽管进行了大量的努力,但仍不清楚HSV-1如何 抑制宿主基因表达以允许有效的病毒复制。遗传学研究 研究表明,ICP 27,由一个必需的立即早期基因编码, 在抑制宿主mRNA生物合成中起重要作用。根据体外试验,早期 研究表明ICP 27阻断宿主基因的转录和剪接。 通过对HSV-1感染后宿主基因表达的高通量分析, ICP 27过度表达,然而,最近的研究发现, 转录或剪接,但只有少数基因的剪接变化。 有趣的是,这些研究发现, 在HSV-1感染的细胞中存在缺陷,并且这种抑制对宿主基因是特异性的。 尽管这些最近的研究为HSV-1诱导的宿主 关闭,HSV-1介导的转录阻断的分子机制 终止仍然是完全未知,不清楚这样一个块是否 这是病毒有效复制所必需的。我们的目标是解决这些重要问题, 这个提议。在我们的初步研究中,我们发现ICP 27特异性地与 必需mRNA 3 ′加工因子CPSF和ICP 27阻断mRNA 3 ′ 处理.由于mRNA 3'加工是转录终止所必需的,我们将 检验ICP 27通过阻断mRNA抑制宿主转录终止的假设 通过CPSF的3'加工,以及ICP 27介导的宿主mRNA加工的破坏 对HSV复制很重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rozanne M Sandri-Goldin其他文献

Rozanne M Sandri-Goldin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rozanne M Sandri-Goldin', 18)}}的其他基金

Herpes simplex virus-mediated regulation of host gene expression
单纯疱疹病毒介导的宿主基因表达调控
  • 批准号:
    10175471
  • 财政年份:
    2018
  • 资助金额:
    $ 35.07万
  • 项目类别:
Herpes simplex virus-mediated regulation of host gene expression
单纯疱疹病毒介导的宿主基因表达调控
  • 批准号:
    9893657
  • 财政年份:
    2018
  • 资助金额:
    $ 35.07万
  • 项目类别:
2009 Viruses and Cells GRC
2009年病毒与细胞GRC
  • 批准号:
    7668123
  • 财政年份:
    2009
  • 资助金额:
    $ 35.07万
  • 项目类别:
Domain structure and interactions of HSV-1 ICP27
HSV-1 ICP27 的结构域结构和相互作用
  • 批准号:
    7058278
  • 财政年份:
    2004
  • 资助金额:
    $ 35.07万
  • 项目类别:
Domain structure and interactions of HSV-1 ICP27
HSV-1 ICP27 的结构域结构和相互作用
  • 批准号:
    6811463
  • 财政年份:
    2004
  • 资助金额:
    $ 35.07万
  • 项目类别:
Domain structure and interactions of HSV-1 ICP27
HSV-1 ICP27 的结构域结构和相互作用
  • 批准号:
    6891329
  • 财政年份:
    2004
  • 资助金额:
    $ 35.07万
  • 项目类别:
Domain structure and interactions of HSV-1 ICP27
HSV-1 ICP27 的结构域结构和相互作用
  • 批准号:
    7226001
  • 财政年份:
    2004
  • 资助金额:
    $ 35.07万
  • 项目类别:
Domain structure and interactions of HSV-1 ICP27
HSV-1 ICP27 的结构域结构和相互作用
  • 批准号:
    7056392
  • 财政年份:
    2004
  • 资助金额:
    $ 35.07万
  • 项目类别:
Domain structure and interactions of HSV-1 ICP27
HSV-1 ICP27 的结构域结构和相互作用
  • 批准号:
    7414022
  • 财政年份:
    2004
  • 资助金额:
    $ 35.07万
  • 项目类别:
HERPES SIMPLEX VIRUS GENE REGULATION
单纯疱疹病毒基因调控
  • 批准号:
    3070917
  • 财政年份:
    1988
  • 资助金额:
    $ 35.07万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 35.07万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 35.07万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 35.07万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 35.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 35.07万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 35.07万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 35.07万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 35.07万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 35.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 35.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了